Related Experiment Videos
Meningeal involvement in Wegener granulomatosis
U Specks1, K G Moder, T J McDonald
1Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Mayo Clinic Proceedings
|August 16, 2000
Summary
Wegener granulomatosis (WG) can cause severe headaches due to meningeal involvement, even during remission. Prompt immunosuppressive therapy is crucial for symptom resolution in these rare cases.
Area of Science:
- Neurology
- Rheumatology
- Immunology
Background:
- Wegener granulomatosis (WG), now known as Granulomatosis with Polyangiitis (GPA), is a systemic vasculitis.
- Meningeal involvement in WG is rare, with diverse clinical presentations.
- Diagnosis can be challenging, especially during periods of clinical remission.
Observation:
- Two patients with WG in remission presented with severe chronic headaches.
- Standard inflammatory markers and cerebrospinal fluid analysis were unremarkable.
- Elevated antineutrophil cytoplasmic antibody (ANCA) titers persisted.
- Head MRI revealed dural enhancement, indicative of meningeal inflammation.
- A meningeal biopsy confirmed active WG in one patient.
Findings:
- Dural enhancement on MRI in patients with WG and unexplained headaches suggests meningeal involvement.
- Persistent ANCA positivity, even in remission, may indicate subclinical disease activity.
- Meningeal biopsy is essential for definitive diagnosis of WG-related meningitis.
Implications:
- This highlights the importance of considering meningeal involvement in WG patients presenting with new neurological symptoms, particularly headaches.
- Aggressive immunosuppressive therapy can effectively manage WG-induced meningeal inflammation.
- Early diagnosis and treatment are critical to prevent long-term neurological complications.